News | September 25, 2022
Aptar Pharma collaborates with Fluidda
The companies will leverage their respective proprietary technology platforms
The companies will leverage their respective proprietary technology platforms
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
The startup plans to provide free technology to dental clinics upon registration.
To set up 50 lifestyle modification centres across the UAE in the next 24 months
The country has been witnessing a progressive reduction in IMR, U5MR and NMR
Diclofenac Sodium Topical Solution USP, 2% w/w (RLD Pennsaid) had estimated annual sales of US $484 million in the US
Kokilaben Hospital is also the first hospital in Navi Mumbai to receive the SMART ICU certification
Sitagliptin is an active ingredient in JANUVIA, JANUMET and JANUMET XR
The plant at Raleigh, North Carolina, USA owned by Aurolife Pharma has received an establishment inspection report (EIR)
Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.
Subscribe To Our Newsletter & Stay Updated
